𝗢𝗔𝗥𝗢 𝗯𝗿𝗲𝗮𝗸𝘀 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗶𝗻 𝗯𝗿𝗶𝗻𝗲 𝗰𝗼𝗻𝗰𝗲𝗻𝘁𝗿𝗮𝘁𝗶𝗼𝗻. ⚙️

Higher recovery, lower energy, and smarter ZLD. Gradiant’s CFRO + SmartOps AI delivers up to 99% recovery and 60% cost savings.

Leading the way in advanced membrane + AI integration.

#OARO #ZLD #Gradiant

R3VOLUTION results presented at two international conferences - R3VOLUTION Project This November, PhD researcher Martin Prado from project partner UPC introduced the R3VOLUTION project at two major international conferences, where he

R3VOLUTION results presented at two international conferences to showcase the project’s progress toward achieving near-zero liquid discharge (NZLD) in energy-intensive industries. More: r3volution.eu/r3volution-r...

#waterreuse #circulareconomy #zld #zeroliquiddischarge

#Archroma needed a partner who could meet the complexity of their operations head-on and deliver results.

Together, we deployed a #ZLD system at their production site in Thailand that recovers up to 95% of #wastewater and reduces purchased water for the plant by 50%.

▶️ Watch how we made it happen:

Zelira Therapeutics share price Zelira Therapeutics (ASX:ZLD) is an asset listed on the ASX, and part of the Health Care sector. Grafa’s asset page shows Zelira Therapeutics’s share price, cha

Zelira Therapeutics ( #ZLD ) has released " Quarterly Activities/Appendix 4C Cash Flow Report " on Wed 30 Jul at 16:29 AEST #tax #government #UnitedStates #ClinicalTrials #Australia

Green hydrogen isn’t clean if the #waterfootprint isn’t.

That’s why we developed ProtiumSource, a complete electrolyzer-ready water solution with feedwater-agnostic performance, integrated brine management, and #ZLD.

Cleaner #hydrogen. Responsible water. Contact us to learn more.

Zelira Therapeutics share price Zelira Therapeutics (ASX:ZLD) is an asset listed on the ASX, and part of the Health Care sector. Grafa’s asset page shows Zelira Therapeutics’s share price, cha

Zelira Therapeutics ( #ZLD ) has released " Zelira Therapeutics Secures R&D Loan Facility " on Thu 24 Jul at 12:05 AEST #tax #UnitedStates #ClinicalTrials #Australia #ltd

Last call! 📣

Tomorrow, Gradiant experts Steven Lam and Keith Kinch explore how CFRO is breaking performance barriers in high-TDS #brinerecovery and Zero Liquid Discharge. This is where #ZLD meets ROI.

➡️ Save your spot or register for the replay: pages.gradiant.com/cfroindustri...

The future of #brinetreatment is here.

Join Gradiant’s live webinar July 16 to see how advanced concentration tech doubles throughput, cuts energy use, and makes #ZLD viable—backed by real results from global leaders like #Archroma.

Register: pages.gradiant.com/cfroindustri...

Global Zero Liquid Discharge Systems Market Research Report 2016-2027 Global Zero Liquid Discharge Systems Market, Share, Revenue, Size, Global, Research Report, Rate, Price, Industry Trends, Analysis, Outlook ,Forecast,

🔍 Explore the latest insights in the Zero Liquid Discharge Systems Market with our in-depth research report 🌊📈. Discover trends, growth drivers, and forecasts shaping the future of sustainable water treatment!

#ZeroLiquidDischarge #WaterTech #MarketResearch #ZLD 💧

Join our webinar on #ProtiumSource—Gradiant’s end-to-end solution for electrolyzer-ready water.

Learn how seawater and wastewater become high-purity input for #greenhydrogen, with lower OPEX and built-in #ZLD.

➡️ Register now: pages.gradiant.com/protiumsourc... (replay available)

Zelira Therapeutics share price Zelira Therapeutics (ASX:ZLD) is an asset listed on the ASX, and part of the Health Care sector. Grafa’s asset page shows Zelira Therapeutics’s share price, cha

Zelira Therapeutics ( #ZLD ) has released " Publication of ZLT-L-007 IRB Approved Observational Study " on Thu 22 May at 08:21 AEST #today #UnitedStates #ClinicalTrials #Australia #media

The R3volution project was presented at the “Desalination for the Environment Clean Water and Energy” Conference in Porto at the end of April.

#desalination #zld #science #researchproject #r3volution #industrialwaterreuse #water #waterreuse

📘深掘り分析記事：激動するLLM市場の深層 – 市場構造、競争力学、そして社会変革へのロードマップ (2025年5月版) - mxt forest Not Found File 📒記事-Mgt/📘深掘り分析記事：激動するLLM市場の深層 – 市場構造、競争力学、そして社会変革へのロードマップ (2025年5月版).md does not exist.

ついに解禁！🤫 LLM市場の現状と未来を、これでもかと深掘りした4万字超レポート。
定量データ、各社戦略、技術トレンド、未来シナリオ、社会への影響…これを読めばLLMの全てがわかる（かも？）。有料級の分析、ぜひご自身の目で。

#生成AI #ディープダイブ #LLM #市場分析 #徹底解説 #ZLD

Zelira Therapeutics share price Zelira Therapeutics (ASX:ZLD) is an asset listed on the ASX, and part of the Health Care sector. Grafa’s asset page shows Zelira Therapeutics’s share price, cha

Zelira Therapeutics ( #ZLD ) has released " Quarterly Activities/Appendix 4C Cash Flow Report " on Tue 29 Apr at 11:06 AEST #tax #government #UnitedStates #ClinicalTrials #Australia

You're seeing a broken man #zeroescape #999 #zerotimedilemma #zld #pngtuber

Zelira Therapeutics share price Zelira Therapeutics (ASX:ZLD) is an asset listed on the ASX, and part of the Health Care sector. Grafa’s asset page shows Zelira Therapeutics’s share price, cha

Zelira Therapeutics ( #ZLD ) has released " Zelira secures $1 Million At-the-Market Funding Facility " on Mon 31 Mar at 08:18 AEST #today #UnitedStates #ClinicalTrials #Australia #Strategy

Zelira Therapeutics share price Zelira Therapeutics (ASX:ZLD) is an asset listed on the ASX, and part of the Health Care sector. Grafa’s asset page shows Zelira Therapeutics’s share price, cha

Zelira Therapeutics ( #ZLD ) has released " Zelira receives $1,153,000 R&D Tax Incentive Scheme Refund " on Tue 18 Feb at 13:32 AEST #tax #government #UnitedStates #ClinicalTrials #Australia